drugset / Trial / NCT07366632
A Study of Single Dose of BL0175 in Postmenopausal Women
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The goal of this clinical trial is to learn the safety and PK of the single dose of BL0175 Injection in postmenopausal women and to compare that with a single dose of Fulvestrant Injection. The main questions it aims to answer are: * What medical problems do participants have when using drug BL0175? * How long can BL0175 remain in your blood? Participants will receive a single dose of drug BL0175 or a single dose of Fulvestrant Injection in a randomized method
Timeline
- Start
- 2026-01-26
- Primary completion
- 2026-05-08
- Completion
- 2026-12-21
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BL0175 | Other / unclassified | 250 mg | — |
| Comparator | Fulvestrant | Small molecule | 250 mg | — |
Indications
No indication recorded.